http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2047850-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef932409e7790f20e23dab0e8aba2087
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6462bb17844ca32ccffe4900594d157
publicationDate 2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2047850-A3
titleOfInvention Methods for treating diseases through inhibition of the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
abstract A method of treating an infectious disease caused by a pathogen comprising administering to a subject in need thereof an effective amount of one or more compounds that inhibit the function of a molecular chaperone, wherein said compound is other than tizoxanide or nitazoxanide.
priorityDate 2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006031566-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5578621-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006025490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1792898-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006042195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5935591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9824887-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414359002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID394397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226706998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514055

Total number of triples: 41.